Abstract
During the past few years, Lewis-acidic ionic liquids (ILs) have emerged from their role as mere reaction media toward a role as novel catalytic systems. Iron-containing chloroferrate ionic liquids in particular offer a novel approach to sustainable and environmentally benign catalysis and can be applied in a surprising diversity of transformations. In this review, we present this emerging topic and report the application of chloroferrate ILs as solvents, catalysts or catalytic systems for a variety of chemical processes, with a particular focus on reactions leading to pharmaceutically active compounds or intermediates.
Keywords: Catalysis, Chloroferrate, Ionic liquids, Synthesis, Sustainable Catalysis, Solvent, 1.1. Friedel, –, Crafts Acylation
Current Organic Synthesis
Title: From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis
Volume: 8 Issue: 6
Author(s): Katharina Bica, Sonja Leder and Peter Gaertner
Affiliation:
Keywords: Catalysis, Chloroferrate, Ionic liquids, Synthesis, Sustainable Catalysis, Solvent, 1.1. Friedel, –, Crafts Acylation
Abstract: During the past few years, Lewis-acidic ionic liquids (ILs) have emerged from their role as mere reaction media toward a role as novel catalytic systems. Iron-containing chloroferrate ionic liquids in particular offer a novel approach to sustainable and environmentally benign catalysis and can be applied in a surprising diversity of transformations. In this review, we present this emerging topic and report the application of chloroferrate ILs as solvents, catalysts or catalytic systems for a variety of chemical processes, with a particular focus on reactions leading to pharmaceutically active compounds or intermediates.
Export Options
About this article
Cite this article as:
Bica Katharina, Leder Sonja and Gaertner Peter, From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis, Current Organic Synthesis 2011; 8 (6) . https://dx.doi.org/10.2174/1570179411108060824
DOI https://dx.doi.org/10.2174/1570179411108060824 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
Current Medicinal Chemistry Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets The Long and Winding Road: Searching for Non-MHC Psoriasis Susceptibility Loci
Current Genomics Relationship Between Polymorphisms of Interleukin-1 Receptor Antagonist (IL-1Ra) Genes and Susceptibility to Systemic Lupus Erythematosus in Iranian Population
Current Rheumatology Reviews Passive Immunization as Tool to Identify Protective HIV-1 Env Epitopes
Current HIV Research Edema, Inflammation and Fibrosis – Comparison Between Catecholamine- and Hypoxia-Induced Pulmonary Injuries
Vascular Disease Prevention (Discontinued) Multifunctional Lipoic Acid Conjugates
Current Medicinal Chemistry Overexpressing Runx2 of BMSCs Improves the Repairment of knee Cartilage Defects
Current Gene Therapy Lifestyle Changes and Pharmacological Risk Factor Modification for Effective Vascular Disease Prevention
Vascular Disease Prevention (Discontinued) Coumarins as Antioxidants
Current Medicinal Chemistry MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Current Genomics Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Current Drug Targets Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models
Anti-Cancer Agents in Medicinal Chemistry Recent Developments in Receptor-Selective Retinoids
Current Pharmaceutical Design An Unbiased Predictive Model to Detect DNA Methylation Propensity of CpG Islands in the Human Genome
Current Bioinformatics Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies
Current Drug Metabolism New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer
Current Drug Targets Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
Current Medicinal Chemistry Effects of Edible Algae Polysaccharides on Allergic, Inflammatory, and Anti-Tumor Responses Through Toll-Like Receptor 4
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry